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Abstract
Background: The potential effect of age-related factors on health-related quality of life (HRQOL) of patients with
epilepsy has rarely been analyzed in the literature.
Methods: We examined this association in a selected population of 815 adults with epilepsy recruited in the
context of a multicentre study for the evaluation of Epi-QoL, one of the first Italian epilepsy-specific measures of
HRQOL for adults with epilepsy. The Epi-QoL is a 46-item self-administered questionnaire focusing on six domains,
which was successfully tested for reproducibility and validity. Ordinary least-squares regression models were used
to assess the relationships between age-related factors (patient’s age, age at seizure onset, and duration of
epilepsy) and overall Epi-QoL score, controlling for the effect of potential confounders. We fitted simple regression
models including each age-related factor alone to assess the independent role of each factor on the overall Epi-
QoL score. We also fitted multiple regression models including pairs of age-related factors solely, as well as one or
two age-related factors together with the same set of confounders.
Results: Simple regression models showed that age and duration of epilepsy were significant negative predictors
of the overall Epi-QoL score: the higher was each age-related factor, the lower was the overall Epi-QoL score; age
at onset alone was a nonsignificant predictor of the overall Epi-QoL score. Multiple regression models including
two age-related factors solely showed that duration of epilepsy was still a significant negative predictor of the
overall Epi-QoL score in both pairwise models, whereas age was a significant negative predictor only in the model
including age at onset. Age at onset emerged as a significant positive predictor of the overall Epi-QoL score only
in the model including age: the higher was age at onset, the higher was the overall Epi-QoL score. Adjusted
regression models including either one or two age-related factors and controlling for the selected confounding
variables showed that the age-related factors had no significant effect on the overall Epi-QoL score anymore.
Conclusions: If no other known correlates of the overall Epi-QoL score are considered, age and duration of
epilepsy can be expected to have a significant negative association with HRQOL in epilepsy (with the effect of
duration being stronger and more consistent across models than the one of age), whereas age at onset is a
positive predictor of the overall HRQOL of limited significance. However, demographic and clinical factors, such as
seizure frequency in the preceding 12 months, may provide a better explanation of HRQOL in epilepsy.
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Background
Patients with epilepsy are at increased risk for poor
health-related quality of life (HRQOL), given the impact
of this disorder on psycho-social dimensions that contri-
bute to form the overall perception of an individual’s
position in life [1-3].
During the past two decades considerable research has
been devoted to developing measures of HRQOL for
epilepsy patients [4,5], and to examining the impact of
demographic (e.g. age, sex, education, socio-economic
status), clinical (e.g. seizure frequency, seizure type,
duration of epilepsy, age at onset, type of drugs and
number), comorbid psychiatric (e.g. anxiety, depression),
and psycho-social (e.g. stigma, social support, self-
efficacy) factors on quality of life [3,6-8].
The potential effect of age-related factors, including
age, age at onset of seizures and duration, on HRQOL of
patients with epilepsy is a source of conceptual and
methodological concern. Potential interest lies in the eva-
luation of the independent contribution of each of these
factors on HRQOL, as well as of their joint effect. Includ-
ing two age-related factors in the same model allows to
estimate the effect of interest adjusting for the effect of
the remaning age-related factor, and this may provide
results that are different from the ones of simple models
including only the age-related factor of interest, in con-
sideration of confounding phenomena. For instance, in
adult patients, since several epilepsies start early in life, a
longer duration of the disorder is heavily confounded by
ageing, which itself is associated with cognitive decline
and poor HRQOL [9]. However, the linear relationship
that links the three age-related factors (say, epilepsy
duration = age - age at onset) prevents the inclusion in
the same model of all the factors as continuous variables.
The major implication of this issue is that one can get a
good overall picture on age-related morbidity and
HRQOL only from the joint evaluation of the three mod-
els including each available pair of age-related factors.
The relationship between age-related factors and
HRQOL in epilepsy patients has rarely been analyzed in
the literature. We identified only one study [10] devoted
to assessing the effects of age, age at onset and epilepsy
duration on HRQOL. Some results on age-related morbid-
ity were obtained as a by-product from studies intended to
address other research questions on HRQOL, measured
according to a variety of validated instruments, in various
subpopulations [11-30]. Moreover, few research efforts
have been devoted to understanding the cognitive burdens
associated with increasing age [9,31], or duration of epi-
lepsy [31-33], and the comorbid interictal psychiatric
symptoms associated with duration of epilepsy too [28].
In the present paper, we examine the independent and
joint effects of age, age at onset and duration of epilepsy
on HRQOL in adult patients with this disorder recruited
in a multicentre Italian study based on one of the first
validated epilepsy-specific questionnaires developed in
Italy [34]. Although these factors are unmodifiable, they
may play a crucial role in the identification of epilepsy
patients at higher risk of poor HRQOL and of targeted
clinical, psychological and social care.
Methods
Subjects
The present analysis was based on data from a multicentre
study including 815 subjects and evaluating the Epi-QoL,
one of the first epilepsy-specific instruments developed in
Italy to measure HRQOL in clinical practice. Details were
given elsewere [34]. Briefly, the 24 secondary and tertiary
Italian centers for the care of epilepsy participating in the
study were asked to recruit up to 30 consecutive patients
meeting the following inclusion criteria: age 18 or older;
diagnosis of epilepsy (at least two unprovoked seizures
24 hours apart) [35]; presence of idiopathic, cryptogenic,
or symptomatic epilepsy according to the ILAE syndromic
classification [36]; good compliance with treatment and
study participation; informed consent; and ability to read
and understand the study questions. A semi-structured
questionnaire including information on socio-
demographic characteristics and clinical variables was
administered to outpatients by trained interviewers. The
study was approved by the local ethics committees.
HRQOL was evaluated through the Epi-QoL instrument.
Measures
The Epi-QoL is a 46-item self-administered question-
naire focusing on 6 domains identified by an expert
panel: Physical Functioning, Cognitive Functioning,
Emotional Well-Being, Social Functioning, Seizure
Worry, and Medication Effects. Subjects have to rate
their HRQOL on a 6-point Likert scale format: ‘almost
always’ (1), ‘very frequently’ (2), ‘sometimes’ (3), ‘a bit’
(4), ‘very little’ (5), ‘not at all’ (6). The instrument was
successfully tested for reproducibility and validity and
showed fairly good psychometric properties [34].
Statistical analysis
Variables of interest
In accordance with the defined aim of the analysis, we car-
ried out a preliminary identification of a set of variables of
interest. This set includes the overall Epi-QoL score as a
measure of HRQOL, the three mentioned age-related fac-
tors (age, age at onset of epilepsy, and duration of epilepsy)
as main variables of interest, and a set of other factors
identified by our panel of experts as potential confounding
variables. The overall Epi-QoL score was calculated for
each patient as the sum of the scores attributed to each
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questionnaire’s item, after reverse coding was applied to
those scores corresponding to questions that were posi-
tively formulated. The higher the score, the greater the
HRQOL perceived [34]. Age, age at onset and duration
were measured in years. Age and age at onset were
obtained from the initial clinical interview and previous
records. Duration of epilepsy was computed by subtracting
age at onset from age. The set of potential confounders
includes the following variables: geographic area of the
study center, gender, education, seizure frequency in the
preceding 12 months, etiology, number of medications,
intellectual functions, and psychiatric disturbances. Details
on the distribution of the confounders in the study sample
were given in the Results section and elsewhere [34].
Descriptive analyses
We computed a kernel density estimate of the distribu-
tion of each age-related factor and of the overall Epi-
QoL score to improve histogram-like representations of
the original data. We adopted a Gaussian smoothing
kernel scaled such that the smoothing bandwidth is the
standard deviation of the kernel [37]. We calculated the
Spearman rank correlation coefficient between each pair
of variables included in the identified set of interest.
Given the large number of subjects (N = 815), values
greater or equal to 0.069 in absolute value were retained
as statistically significant at the a = 005 level [38].
Regression models
Ordinary least-squares regression models were used to
assess the relationships between age-related factors, poten-
tial confounders and overall Epi-QoL score, with overall
Epi-QoL score being the dependent variable, and age-
related factors and potential confounders the independent
variables. For each age-related factor, we ran a simple
regression model, followed by a multiple model including
all the potential confounders. We also fitted models
including pairs of age-related variables solely and in com-
bination with all the potential confounders.
To improve interpretability of the regression coefficients,
we considered the age-related factors within each of the
previous models as continuous (in years) as well as catego-
rical variables, with categories defined as in the provided
tables.
Checks of regression diagnostics were carried out for all
the fitted models and revealed only limited adherence to
the model assumption on normality of the error. However,
as the p-values obtained from the corresponding models
with a Box-Cox transformation of the response variable
(yl = 2.3) [39,40] were similar to those obtained from the
original models, we decided to present the results obtained
from the original models with no transformation of the
dependent variable.
Calculations were performed using the open-source
statistical computing environment R [41,42], and its
libraries “MASS” [43] and “faraway” [44].
Results
The demographic and clinical characteristics of the
study sample are described elsewhere [34]. Briefly,
patients had a median age of 36 years, a median epilepsy
duration of 16 years, and a median age at onset of sei-
zures of 16 years. Almost 40% of patients had no sei-
zures in the preceding 12 months, 25.5% had from 1 to
5 seizures, 13% from 6 to 20, and 21.7% had more than
20 seizures. Most of the patients had focal (74.3%) or
generalized (22.2%) epilepsy, were in remission for more
than a year (53.4%) or had non-drug-resistant seizures
(20.3%), and were in monotherapy (54.1%) or polyther-
apy (44.3%).
Figure 1 shows the kernel density estimation plot of
the univariate distributions of age-related factors and
overall Epi-QoL score, plotted along with the quartiles
and the mean of each variable. The density estimates
provide an indication of the general tendency of each
variable to distribute on the range of its possible values.
Here, all the density estimates emerged to be highly
skewed, with the age-related densities that were skewed
to the right and the overall Epi-QoL score density that
was skewed to the left. Accordingly, in the age-related
factor plots, the means were larger than the correspond-
ing medians (Q2), whereas in the overall Epi-QoL score
plot the mean was smaller than the corresponding
median (Q2).
Table 1 shows the Spearman rank correlation coeffi-
cients, r, between the identified variables of interest. As
expected, the correlations among the age-related vari-
ables were high in absolute value, with the smallest
absolute value given by 0.39 and the highest given by
0.59. Age was positively correlated with age at onset
(r = 0.42) and duration of epilepsy (r = 0.39), the latter
two variables were negatively correlated (r = -0.59). The
overall Epi-QoL score was correlated with the following
potential confounders: seizure frequency in the preced-
ing 12 months, psychiatric disturbances, number of
drugs, and intellectual functions, but it was correlated
only weakly with the age-related factors (see [34] and
the beginning of this section for details on these
variables).
Results from the fitted regression models with contin-
uous age-related factors are summarized below. Simple
regression models including just one age-related factor
showed that age at onset was not a significant predictor
(b = 0.13, p = 0.188), whereas age and duration of epi-
lepsy were significant negative predictors of the overall
Epi-QoL score (b = -0.24, p = 0.025, and b = -0.46, p <
0.001, respectively). Multiple regression models includ-
ing two age-related factors showed that duration of epi-
lepsy was still a significant negative predictor of the
overall Epi-QoL score in both pairwise models (with
age: b = -0.42, p < 0.001, with age at onset: b = -0.51,
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Figure 1 Kernel density estimation plot of the univariate distributions of the age-related factors and overall Epi-QoL score. Density
estimates were plotted along with quartiles and means of each variable. In each plot, Q1, Q2 and Q3 indicated the first, second (median), and
third quartile, respectively. The bandwidths were about 3.34, 3.11, 2.81, 10.28 for age, duration, age at onset, and overall Epi-QoL score,
respectively.
Table 1 Spearman rank correlation coefficients between age-related variables, overall Epi-QoL score and demographic
and clinical characteristics (N = 815)a
A Ao D O-Epi Sf Pd G Nd If Ed Ga Et
A 1.00
Ao 0.42 1.00
D 0.39 -0.59 1.00
O-Epi -0.08 0.05 -0.12 1.00
Sf 0.08 -0.06 0.11 -0.41 1.00
Pd 0.11 0.02 0.07 -0.21 0.08 1.00
G 0.06 0.15 -0.12 0.13 -0.06 -0.06 1.00
Nd 0.09 -0.23 0.31 -0.29 0.40 0.08 -0.03 1.00
If -0.05 0.19 -0.20 0.21 -0.11 -0.14 -0.01 -0.18 1.00
Ed 0.09 0.04 0.05 -0.04 0.04 0.04 0.05 0.08 -0.04 1.00
Ga -0.08 -0.09 0.03 -0.13 0.09 -0.02 0.03 0.01 -0.01 -0.00 1.00
Et 0.08 -0.04 0.07 -0.08 0.07 -0.05 0.03 0.07 -0.14 0.03 -0.05 1.00
aValues greater or equal to 0.069 in absolute value were retained as statistically significant at the a = 0.05 level and were shown in bold typeface.
A: Age; Ao: Age at onset; D: Duration of epilepsy; O-Epi: Overall Epi-QoL score; Sf: Seizure frequency (12 months); Pd: Psychiatric disturbances; G: Gender; Nd:
Number of drugs; If: Intellectual functions; Ed: Education; Ga: Geographic area; Et: Etiology.
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p < 0.001), and its effect was comparable in size to the
one that emerged from the simple model including
duration only. Age was a significant predictor of the
overall Epi-QoL score only in the model including age
at onset (b = -0.51, p < 0.001), whereas it was nonsigni-
ficant when duration was included in the model (b =
-0.10, p = 0.406). In both models, the coefficient beta
for age was still negative, and it was stronger than in
the simple age-model, when age at onset was included
in the model. Age at onset emerged as a significant pre-
dictor of the overall Epi-QoL score in the model includ-
ing age (b = 0.42, p < 0.001), but not when duration
was included (b = -0.10, p = 0.406). When significant,
age at onset had a positive effect on the overall Epi-QoL
score. Adjusted regression models including either one
or two age-related factors, as well as the selected con-
founding variables, showed that the age-related factors
had no significant effect on the overall Epi-QoL score.
Table 2 and 3 summarize the results coming from the
fitted regression models with categorical age-related fac-
tors. Type-1 models include only the age-related vari-
ables (either one or two of them) as predictors of the
overall Epi-QoL score. Type-2 models include the age-
related variables (either one or two of them) and the
selected potential confounders (as listed in the left outer
column of the tables). Results were generally consistent
with those obtained from the regression models includ-
ing the continuous age-related factors, but the magnitude
of the effects was more evident. Categories 40- < 50 and
50- < 60 years for age, 30- < 40 and ≥ 40 years for dura-
tion of epilepy, and 10- < 25 and ≥ 55 for age at onset
emerged as statistically significant across the fitted mod-
els. In detail, type-1 simple models showed that the
decrease in the overall Epi-QoL score given, say, by a
chronological age between 50 and 60 years (compared to
being less than 30 years) was of about 17 points (b =
-16.63, p = 0.002), and that the decrease given by a dura-
tion of epilepsy of, say, more than 40 years (compared to
a duration of less than 10 years) was of about 19 points
(b = 19.37, p = 0.002). Moreover, an age at onset between
10 and 25 years (compared to having an onset at 10 years
or less) provided a significant increase in the overall Epi-
QoL score of about 8 points (b = 7.78, p = 0.043). In the
type-1 multiple models, duration of epilepsy remained
significant and equally strong, age at onset attained some
significance, whereas the association with age either
remained stable and significant or became weaker and
nonsignificant. Type-2 models showed that none of the
age-related variables had significant effects on the overall
Epi-QoL score, after adjusting for the selected confoun-
ders. For both continuous and categorical age-related
models, seizure frequency in the preceding 12 months,
psychiatric disturbances, number of medications,
geographic area of the study center, gender, intellectual
functions, and education explained most of the overall
Epi-QoL score, and were, therefore, more relevant deter-
minants of HRQOL (measured according to the overall
Epi-QoL score) than age-related factors. This was evident
in the comparison between the adjusted R2s (percentage
of total variability in the outcome that is accounted for
by the entire set of predictors) across type-1 and corre-
sponding type-2 models: type-2 models provided
approximately 25% of the explanation for the overall Epi-
QoL score, compared with 0.4, 1, and 2% for models with
age at onset, age, and duration of epilepsy alone, respec-
tively. Most of this 25% was attributable to the seizure
frequency in the preceding 12 months (data not shown).
Discussion
The present analysis is devoted to the elucidation of the
role of age, age at seizure onset, and epilepsy duration on
HRQOL in an Italian multicentre study on epilepsy
patients based on the validated and specific Epi-QoL
questionnaire. It emerges that, if no other known corre-
lates of the overall Epi-QoL score are considered, age and
duration of epilepsy can be expected to have a significant
consistent negative association, and age at onset a posi-
tive association of limited significance (i.e. significant in
one model only), with HRQOL in epilepsy. However,
none of the age-related variables showed a significant
effect on the overall Epi-QoL score, after adjusting for a
selected set of confounders including demographic and
clinical factors, and, in particular, the seizure frequency
in the preceding 12 months.
The main conclusion of a modest role of age-related
factors as determinants of HRQOL is consistent with
the vast majority of the literature reports on the deter-
minants of HRQOL in epilepsy patients [11-30], includ-
ing the only available study published on the same topic
to our knowledge [10], where the effects of age at onset
and duration were no longer significant, after adding
Profile of Mood States Depression/Dejection, Adverse
Events Profile, comorbidities, and antiepileptic drugs to
the regression models.
Nonsignificance of age-related factors has rarely been
reported in simple models [10,12], but is more common
when results come from multiple models including age-
related factors and other clinical variables, such as mea-
sures of psychiatric comorbidity, number of antiepileptic
medications, and seizure severity, as in Szaflarski and
coauthors [10,11,15,16,26]. The instrument used to mea-
sure HRQOL may also play a role, as specific measures
were found to be more sensitive in detecting variation
in age at onset and other clinical variables than generic
measures [14].
Significant but modest effects of age-related factors on
HRQOL in epilepsy patients have been reported in
other papers, even after adjustment for other known
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Table 2 Ordinary least-squares regression models with categorical age-related factors as main effects: results from
models including single age-related factors (N = 815)a
Age-related factor N % N %
Age Age at onset
<30 238 29.2 <10 188 23.1
30-<40 246 30.2 10-<25 407 49.9
40-<50 149 18.3 25-<55 180 22.1
50-<60 93 11.4 ≥ 55 40 4.9
≥60 89 10.9
Duration of epilepsy
<10 244 29.9
10-<20 207 25.4
20-<30 184 22.6
30-<40 122 15.0
≥ 40 58 7.1
Predictor variable Type-1 Model Type-2 Model
b SE p b SE p
Age
30-<40 -4.68 3.95 0.237 0.39 3.51 0.911
40-<50 -10.52 4.54 0.021 -4.13 4.13 0.318
50-<60 -16.63 5.31 0.002 -8.94 4.83 0.065
≥ 60 -5.44 5.40 0.314 1.37 5.08 0.787
Seizure frequency in preceding 12 months
1-5 vs seizure free -18.59 3.48 <0.001
6-20 vs seizure free -23.65 4.47 <0.001
≥20 vs seizure free -33.12 4.02 <0.001
Psychiatric disturbances
yes vs no -19.97 4.03 <0.001
Gender
male vs female 8.22 2.71 0.002
Therapy
monotherapy vs polytherapy 9.24 3.03 0.002
no therapy vs polytherapy 17.86 10.91 0.102
Intellectual functions
compromised vs normal -12.35 4.10 0.003
Education
9-13 years vs <9 years 6.95 3.14 0.027
≥ 14 years vs <9 years 9.97 4.17 0.017
Geographic area
central Italy vs northern Italy -2.47 3.29 0.452
southern Italy vs northern Italy -12.93 3.45 <0.001
Etiology
cryptogenic vs symptomatic 4.09 3.08 0.184
idiopathic vs symptomatic 3.11 3.85 0.419
Intercept 213.51 2.82 <0.001 216.65 5.49 <0.001
R2 0.01 0.25
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Table 2 Ordinary least-squares regression models with categorical age-related factors as main effects: results from
models including single age-related factors (N = 815)a (Continued)
Age at onset
10-<25 7.78 3.84 0.043 -2.04 3.45 0.555
25-<55 3.17 4.55 0.486 -6.93 4.18 0.098
≥ 55 13.54 7.59 0.075 5.67 6.90 0.412
Seizure frequency in preceding 12 months
1-5 vs seizure free -18.86 3.50 <0.001
6-20 vs seizure free -23.43 4.48 <0.001
≥ 20 vs seizure free -33.22 4.02 <0.001
Psychiatric disturbances
yes vs no -20.20 4.01 <0.001
Gender
male vs female 8.040 2.720 0.003
Therapy
monotherapy vs polytherapy 10.24 3.07 <0.001
no therapy vs polytherapy 18.66 10.93 0.088
Intellectual functions
compromised vs normal -12.70 4.15 0.002
Education
9-13 years vs <9 years 7.86 3.06 0.010
≥ 14 years vs <9 years 11.73 4.08 0.004
Geographic area
central Italy vs northern Italy -2.14 3.28 0.514
southern Italy vs northern Italy -12.25 3.38 <0.001
Etiology
cryptogenic vs symptomatic 4.71 3.10 0.129
idiopathic vs symptomatic 3.05 3.88 0.431
Intercept 202.43 3.18 <0.001 215.86 5.04 <0.001
R2 0.01 0.25
Duration of epilepsy
10-<20 2.32 4.09 0.571 4.42 3.65 0.226
20-<30 -3.04 4.22 0.471 4.25 3.88 0.273
30-<40 -13.53 4.80 0.005 2.13 4.48 0.634
≥ 40 -19.37 6.32 0.002 -6.78 5.84 0.246
Seizure frequency in preceding 12 months
1-5 vs seizure free -18.15 3.49 <0.001
6-20 vs seizure free -23.06 4.48 <0.001
≥ 20 vs seizure free -32.12 4.03 <0.001
Psychiatric disturbances
yes vs no -20.18 4.02 <0.001
Gender
male vs female 8.48 2.71 0.002
Therapy
monotherapy vs polytherapy 9.88 3.15 0.002
no therapy vs polytherapy 20.22 10.95 0.065
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Table 2 Ordinary least-squares regression models with categorical age-related factors as main effects: results from
models including single age-related factors (N = 815)a (Continued)
Intellectual functions
compromised vs normal -12.13 4.12 0.003
Education
9-13 years vs <9 years 6.89 3.07 0.025
≥ 14 years vs <9 years 10.16 4.09 0.013
Geographic area
central Italy vs northern Italy -2.45 3.30 0.459
southern Italy vs northern Italy -13.32 3.43 <0.001
Etiology
cryptogenic vs symptomatic 4.54 3.08 0.141
idiopathic vs symptomatic 3.91 3.78 0.301
Intercept 211.18 2.77 <0.001 212.07 5.62 <0.001
R2 0.02 0.25
aType-1 models include only the age-related variables as predictors of the overall Epi-QoL score. Type-2 models include the age-related variables and the
selected potential confounders (as listed in the left outer column of the table). All variables included in the models were shown.b: unstandardized regression
coefficient; SE: standard error.
Table 3 Ordinary least-squares regression models with categorical age-related factors as main effects: results from
models including available pairs of age-related factors (N = 815)a
Predictor variable Type-1 Model Type-2 Model
b SE p b SE p
Age
30-<40 -4.82 4.00 0.228 1.03 3.57 0.773
40-<50 -10.98 4.75 0.021 -2.79 4.33 0.520
50-<60 -18.41 5.57 <0.001 -7.85 5.10 0.124
≥ 60 -12.32 6.61 0.063 0.08 6.13 0.989
Age at onset
10-<25 7.01 3.83 0.068 -2.03 3.45 0.557
25-<55 7.88 4.75 0.097 -5.51 4.44 0.215
≥ 55 20.89 9.05 0.021 5.80 8.19 0.479
Seizure frequency in preceding 12 months
1-5 vs seizure free -18.77 3.50 <0.001
6-20 vs seizure free -23.76 4.49 <0.001
≥ 20 vs seizure free -33.54 4.03 <0.001
Psychiatric disturbances
yes vs no -19.77 4.03 <0.001
Gender
male vs female 8.13 2.73 0.003
Therapy
monotherapy vs polytherapy 9.61 3.10 0.002
no therapy vs polytherapy 17.06 10.97 0.120
Intellectual functions
compromised vs normal -12.84 4.15 0.002
Education
9-13 years vs <9 years 7.33 3.15 0.020
≥ 14 years vs <9 years 10.84 4.20 0.010
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Table 3 Ordinary least-squares regression models with categorical age-related factors as main effects: results from
models including available pairs of age-related factors (N = 815)a (Continued)
Geographic area
central Italy vs northern Italy -2.32 3.29 0.480
southern Italy vs northern Italy -12.71 3.46 <0.001
Etiology
cryptogenic vs symptomatic 4.58 3.11 0.141
idiopathic vs symptomatic 2.72 3.90 0.486
Intercept 208.32 3.95 <0.001 217.69 5.87 <0.001
R2 0.01 0.25
Age
30-<40 -2.40 4.12 0.561 -0.77 3.67 0.834
40-<50 -5.11 4.89 0.296 -4.50 4.44 0.311
50-<60 -8.80 5.81 0.130 -8.00 5.28 0.130
≥ 60 0.99 5.75 0.863 3.49 5.40 0.519
Duration of epilepsy
10-<20 2.54 4.12 0.538 4.62 3.66 0.207
20-<30 -1.91 4.37 0.663 5.18 4.01 0.197
30-<40 -10.57 5.17 0.041 4.83 4.79 0.314
≥ 40 -17.02 6.89 0.014 -5.02 6.34 0.429
Seizure frequency in preceding 12 months
1-5 vs seizure free -18.19 3.50 <0.001
6-20 vs seizure free -23.33 4.49 <0.001
≥ 20 vs seizure free -32.64 4.04 <0.001
Psychiatric disturbances
yes vs no -20.07 4.04 <0.001
Gender
male vs female 8.49 2.72 0.002
Therapy
monotherapy vs polytherapy 9.74 3.15 0.002
no therapy vs polytherapy 18.63 10.97 0.090
Intellectual functions
compromised vs normal -12.44 4.15 0.003
Education
9-13 years vs <9 years 7.15 3.15 0.024
≥ 14 years vs <9 years 10.28 4.17 0.014
Geographic area
central Italy vs northern Italy -2.51 3.31 0.449
southern Italy vs northern Italy -13.21 3.47 <0.001
Etiology
cryptogenic vs symptomatic 4.49 3.09 0.146
idiopathic vs symptomatic 3.30 3.89 0.397
Intercept 212.82 3.43 <0.001 213.15 6.09 <0.001
R2 0.02 0.25
Age at onset
10-<25 1.08 4.22 0.797 -3.59 3.75 0.339
25-<55 -5.21 5.23 0.319 -8.17 4.76 0.086
≥ 55 3.64 8.49 0.668 5.29 7.78 0.497
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important determinants [14,17-22,24,25]. However, some
inconsistencies emerged in the sign of the effect of the
age-related factors on HRQOL.
In our analysis, age was a relevant determinant of
HRQOL: its negative impact on HRQOL emerged from
all the three type-1 models, with statistical significance
of the coefficients given in two of them. This is in
accordance with findings from an analysis based on ado-
lescents [19], where older patients (14-17 years), inde-
pendent of epilepsy severity, reported worse overall
HRQOL than did their younger counterparts, and with
several studies on chronic health problems and HRQOL
[45]. However, in one of the few reported studies that
focuses on age in epilepsy adults, Pugh and colleagues
[18] reported that older adults (65 years and older)
seemed to have less compromised QOL (as measured
using a generic health status measure, the SF-36) than
young (18-40 years) and middle-aged (41-64 years)
adults. Ageing is associated with a mean decline in
learning and memory performances, and, although this
decline was apparently similar for epilepsy patients and
healthy subjects, the former group reached poor perfor-
mance levels much earlier than the latter, as epilepsy
patients may fail to build up adequate learning and
memory performance during childhood and adolescence
[9]. This may have important implications in terms of a
limited HRQOL. Moreover, age is generally associated
with an increased number of chronic health problems,
and multiple chronic health problems are significantly
associated with a reduced HRQOL, in particular with
Table 3 Ordinary least-squares regression models with categorical age-related factors as main effects: results from
models including available pairs of age-related factors (N = 815)a (Continued)
Duration of epilepsy
10-<20 1.58 4.34 0.715 4.32 3.86 0.263
20-<30 -3.86 4.69 0.411 3.45 4.27 0.418
30-<40 -14.47 5.46 0.008 0.54 5.07 0.914
≥ 40 -20.60 7.02 0.003 -9.04 6.48 0.164
Seizure frequency in preceding 12 months
1-5 vs seizure free -18.49 3.50 <0.001
6-20 vs seizure free -23.19 4.48 <0.001
≥ 20 vs seizure free -32.71 4.03 <0.001
Psychiatric disturbances
yes vs no -19.75 4.03 <0.001
Gender
male vs female 8.34 2.72 0.002
Therapy
monotherapy vs polytherapy 9.99 3.14 0.002
no therapy vs polytherapy 18.37 10.97 0.094
Intellectual functions
compromised vs normal -12.74 4.15 0.002
Education
9-13 years vs <9 years 7.26 3.11 0.020
≥ 14 years vs <9 years 11.06 4.15 0.008
Geographic area
central Italy vs northern Italy -2.46 3.30 0.457
southern Italy vs northern Italy -13.32 3.46 <0.001
Etiology
cryptogenic vs symptomatic 5.231 3.106 0.093
idiopathic vs symptomatic 3.264 3.888 0.401
Intercept 212.22 5.21 <0.001 215.85 7.03 <0.001
R2 0.03 0.26
aType-1 models include only the age-related variables as predictors of the overall Epi-QoL score. Type-2 models include the age-related variables and the
selected potential confounders (as listed in the left outer column of the table). All variables included in the models were shown.b: unstandardized regression
coefficient; SE: standard error.
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reduced levels of physical and emotional functioning
[45]. In patients with a previous diagnosis of epilepsy,
the ability of coping with new chronic health problems
and their consequences, together with epilepsy severity,
may be crucial in the evaluation of the role of age on
HRQOL.
From our analysis, it emerged that duration of epi-
lepsy had a consistent significant negative effect on
HRQOL in both single and pairwise unadjusted models.
This is still in agreement with findings from studies on
epilepsy adolescents, where a longer duration of epilepsy
had a significant negative impact on the memory and
concentration subscale of QOLIE-AD-48 [19] and on
the overall HRQOL [17], and with various reports on
the effects of disorder duration for other chronic condi-
tions, such as Parkinson’s disease [46]. However, in Sza-
flarski and coauthors [10], duration had a significant
positive effect on HRQOL in the simple regression
model. Even in presence of working adjustments of the
social and psychological consequences of the disorder
and coping mechanisms, cognitive decline and emo-
tional-behavioral distress, together with a potentially
increased number of drugs, may lead epilepsy subjects
to give a poorer evaluation of HRQOL. Indeed, some
studies assessing verbal learning and memory skill of
epilepsy patients with ad-hoc inventories suggested a
slow cognitive decline with increased duration of epi-
lepsy [32,33]. A relevant investigation [28] demonstrated
that increasing years of duration of temporal lobe epi-
lepsy was modestly associated with increased and gener-
alized self-reported emotional-behavioral distress, even
after adjustment for potentially confounding clinical
variables (including age of onset), and that this comor-
bid emotional-behavioral distress was significantly asso-
ciated with a poorer HRQOL.
Finally, in our paper, age at onset emerged as a posi-
tive predictor of limited significance (in one model out
of three) for the overall Epi-QoL. Accordingly, consis-
tent evidence has been reported from studies on epi-
lepsy children and adolescents, with two studies [14,17]
suggesting that an earlier age of epilepsy onset was asso-
ciated with poorer HRQOL. In one study on adults who
had operations for refractory extratemporal epilepsy
[24], onset at an older age predicted a minimal increase
in the overall health scores, but not in the total HRQOL
score, in both single and multiple models. On the con-
trary, the paper by Szaflarski and coauthors [10] and
two others [21,22] suggested that adding years to age at
onset decreased HRQOL. In detail, in the same popula-
tion of young epilepsy adults with mild intellectual dis-
abilities, epilepsy/disability onset in adolescence (after
the age of 10 years, compared with disability onset dur-
ing childhood) was associated with poorer HRQOL,
both independently and in interaction with neuroticism
[21,22]. The first set of studies, including our analysis,
provided data supporting the association between poorer
seizure control, diminished neuropsychological function-
ing, and low HRQOL in patients with an earlier onset of
epilepsy. However, the role of age at epilepsy onset
deserves further attention, especially in its joint effect
with age, in consideration of how epilepsy can interfere
with brain maturation and then can affect cognitive
functioning in the long term [9].
A possible explanation of the differences in significance
and sign of the age-related beta coefficients across the
papers may be found in the different set of covariates
included as potential confounders in the regression mod-
els, and in the different populations under consideration.
For instance, while Szaflarski and coauthors [10] restricted
the analyses to adult patients with medication-resistant
epilepsy from a US epilepsy monitoring center, we based
our analyses on the overall study population of adult
patients recruited in secondary and tertiary Italian centers
for the care of epilepsy. When we selected the subgroup of
medication-resistant epilepsy patients and carried out the
same pool of analyses, the significant associations pre-
viously identified in the type-1 models disappeared, and
none of the age-related factors were found to be relevant
in the explanation of HRQOL. Although nonsignificant,
the signs of the linear associations between age-related
factors and HRQOL were more similar to those in Sza-
flarski et al. [10]: age at onset emerged as negatively asso-
ciated with HRQOL across all the fitted models, and the
estimated beta coefficient for duration changed its sign to
positive in the pairwise model with age (data not shown).
Conclusions
The Epi-QoL questionnaire was developed with the
scope of creating a specific instrument to address
needs and expectations of the Italian epilepsy adults in
their evaluation of HRQOL. It was validated success-
fully through a multicentre study, showing fairly good
psychometric properties. This paper attempts to use
the promising results from this study to address a spe-
cific research question on the role of age-related fac-
tors as determinants of HRQOL, as measured by the
overall Epi-QoL score. The main conclusion is that
age, age at onset, and duration of epilepsy have only a
limited role in determining the overall HRQOL: age
and duration of epilepsy show a generally significant
negative effect (with the effect of duration being stron-
ger and more consistent across models than the one of
age), and age at onset a positive effect of limited signif-
icance, when considered alone or with another age-
related factor; however, when other correlates of the
overall Epi-QoL score are included in the regression
models, any significant effect of the age-related factors
disappears.
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